Focused Wealth Management’s Cambria Cannabis ETF TOKE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-175
Closed -$1.02K 900
2023
Q4
$1.02K Buy
175
+3
+2% +$17 ﹤0.01% 856
2023
Q3
$993 Buy
172
+2
+1% +$12 ﹤0.01% 850
2023
Q2
$983 Buy
170
+2
+1% +$12 ﹤0.01% 885
2023
Q1
$1.05K Buy
168
+1
+0.6% +$7 ﹤0.01% 864
2022
Q4
$1.12K Buy
167
+1
+0.6% +$7 ﹤0.01% 858
2022
Q3
$1K Buy
166
+1
+0.6% +$8 ﹤0.01% 903
2022
Q2
$1K Hold
165
﹤0.01% 878
2022
Q1
$2K Hold
165
﹤0.01% 818
2021
Q4
$2K Buy
165
+1
+0.6% +$13 ﹤0.01% 836
2021
Q3
$2K Buy
164
+2
+1% +$31 ﹤0.01% 834
2021
Q2
$3K Buy
162
+1
+0.6% +$18 ﹤0.01% 798
2021
Q1
$3K Buy
161
+1
+0.6% +$20 ﹤0.01% 788
2020
Q4
$2K Buy
160
+2
+1% +$27 ﹤0.01% 749
2020
Q3
$2K Buy
158
+3
+2% +$37 ﹤0.01% 705
2020
Q2
$2K Buy
155
+3
+2% +$35 ﹤0.01% 693
2020
Q1
$2K Buy
152
+2
+1% +$26 ﹤0.01% 630
2019
Q4
$2K Buy
+150
New +$2.46K ﹤0.01% 648

Other funds holding TOKE

Focused Wealth Management's TOKE Position: Q1 2024 in Review

Focused Wealth Management sold out of Cambria Cannabis ETF (TOKE) in Q1 2024, closing a stake of 175 shares — an estimated $1.02K sold.

Focused Wealth Management first reported a position in TOKE in Q4 2019 and held it in 17 quarters. The position peaked at $3K in Q2 2021. 17 funds tracked by Wall St. Rank hold TOKE as of Q1 2024.

  • Focused Wealth Management reported no remaining Cambria Cannabis ETF position as of Q1 2024 after selling out during the quarter.
  • Focused Wealth Management sold 175 Cambria Cannabis ETF shares in Q1 2024, an estimated $1.02K.
  • Focused Wealth Management first reported a position in Cambria Cannabis ETF in Q4 2019 and held it in 17 quarters.
  • Focused Wealth Management's Cambria Cannabis ETF position peaked at $3K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.